Attempts were being made to introduce the HPV vaccine in the country, SJM Ashwani Mahajan co-convener said in a letter to the prime minister, saying it would be an "unmitigated tragedy".
Claiming that a World Health Organisation (WHO) report showed that this vaccine has the highest rate of adverse effects among all the vaccines in use, Mahajan said some of which were "seriously debilitating".
"Swadeshi Jagran Manch requests you to stop this move to introduce the HPV vaccine in India and we recommend the strongest action against groups that pervert science, which brings ignominy to the scientific community in the country and sells the country to vested interests," he said in the letter.
Mahajan said some big pharma firms have managed to introduce the vaccine in Punjab although it does not have the approval of the National Technical Advisory Group on Immunisation (NTAGI).
The SJM said that the usage of the vaccine is not allowed by the NTAGI but states can allow its introduction as health is a state subject.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
